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Oral cavityHuman saliva is a biological ﬂuid of great importance in the ﬁeld of dissolution testing. However, until
now, no consensus has been reached on its key characteristics relevant to dissolution testing. As a result,
it is difﬁcult to select or develop an in vitro dissolution medium to best represent human saliva. In this
study, the pH, buffer capacity, surface tension, viscosity and ﬂow rate of both unstimulated (US) and
stimulated (SS) human saliva were investigated in order to provide a platform of reference for future dis-
solution studies using simulated salivary ﬂuids. Age and gender related differences in a sample size of 30
participants for each parameter were investigated. Signiﬁcant differences were established between US
and SS for all characteristics except surface tension. Therefore, the requirement for using two simulated
salivary ﬂuids should be considered when developing an oral dissolution model.
 2015 Elsevier B.V. All rights reserved.1. Introduction
The oral cavity as a dissolution site is often overlooked due to
rapid oral transit as conventional dosage forms are swallowed.
However conventional oral formulations such as tablets and
capsules are of limited application in the paediatric and geriatric
population and alternative oral dosage forms which reside in the
mouth for a signiﬁcant time are increasing in popularity [1]. In
addition, adult dosage forms which can be taken ‘‘on the move’’,
without the co-administration of water are also gaining interest
[2]. Many alternative formulations, such as oral ﬁlms, sublingual
and buccal tablets and orally disintegrating tablets rely on dissolu-
tion or disintegration in saliva. On the contrary, taste masked oral
dosage forms often aim to reduce drug dissolution in saliva in
order to prevent contact between the unpleasant tasting active
pharmaceutical ingredient (API) and the taste buds [3]. Saliva
therefore plays a critical role in the dissolution and performance
of these formulations. However, there is no consensus on the key
characteristics of human saliva which may affect dissolution, and
as a result, it is difﬁcult to select or develop an in vitro dissolutionmedium to best represent human saliva in the evaluation of these
dosage forms.
A number of parameters can be considered as highly inﬂuential
on in vitro dissolution. The pH, buffer capacity and surface tension
are identiﬁed as some of the most important factors [4]. Addition-
ally, viscosity is considered in many cases [5]. Furthermore, Wang
et al. described biorelevant dissolution and suggested consider-
ation of pH, buffer capacity, surface tension and viscosity of the
medium to be paramount for biorelevant dissolution testing (along
with non-medium related hydrodynamic factors such as volume,
ﬂow, agitation and apparatus) [6]. The importance of these partic-
ular parameters is evident as similar approaches have been
adopted in the characterisation of other gastro-intestinal ﬂuids
[7–13]. Extensive research has been carried out over the past few
decades in the design and development of, and application of, bio-
relevant media representing other gastro-intestinal ﬂuids in both
the fed and fasted states [11,14–20]. However, saliva remains less
well characterised. Without knowledge of these crucial medium
parameters in human saliva, it would prove impossible to develop
or select a biorelevant simulated salivary ﬂuid for dissolution stud-
ies. This paper therefore aims to address the gap in the character-
isation of human biological ﬂuids through the investigation of key
parameters of saliva.
The pH of a dissolution medium is important since it affects ion-
isation of the API, according to the Henderson–Hasselbalch equa-
tion, and ionisation is directly linked with the aqueous solubility
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medium to resist changes in pH as an acidic or basic drug begins
to dissolve, i.e. the medium’s buffer capacity. This was demon-
strated by Tsume et al. [22] who performed dissolution experi-
ments in media of different buffer capacities with the acidic drug
ibuprofen and found that when the buffer capacity was low, the
pH decreased to a greater extent as dissolution proceeded, which
hindered the rate and extent of further dissolution.
The pH of human saliva has been described previously, with
varying results in the wide range of 5.3–7.8, depending on the
stimulation state [10,23]. In most studies, either unstimulated sal-
iva (US) or stimulated saliva (SS) was investigated, but not both
[24,25]. Additionally, studies in which the pH of both types of sal-
iva was investigated generally had a small number of participants,
or focussed on just one or two salivary characteristics relevant to
dissolution testing, such as Bardow et al. [26] who investigated
only the pH and buffer capacity. We aim to address this issue by
characterising the pH of both US and SS, as well as other key
parameters within the same sample.
Buffer capacity has been investigated in numerous studies.
However, in most cases, the experimental design employed does
not allow one to draw conclusions about the actual buffer capacity
value or range. Literature values are reported in different ways.
Some research groups have simply quoted the buffer capacity to
be high, medium or low, without providing any actual value [27].
Thus one cannot draw direct comparisons between studies. Some
researchers simply state the bicarbonate concentration of saliva
samples to infer buffer capacity [28]. Furthermore, in some cases,
buffer capacity is quoted in mmol L1 pH1 [26,29]. The lack of
similarity in experimental design has led to inconclusive ﬁndings
regarding the buffer capacity of saliva. This research aims to
address these issues by assessing the buffer capacity of saliva using
similar experimental design to that used for other gastro-intestinal
ﬂuids [12,13,16,20] to allow for comparison.
Viscosity is another key parameter affecting dissolution. A high
viscosity medium would increase the thickness of the boundary
layers (h) and decrease the diffusion coefﬁcient (D) according to
the Noyes–Witney dissolution model, thus reducing the drug dis-
solution rate compared with a medium of lower viscosity [30].
Despite viscosity of stimulated and unstimulated whole human
saliva being evaluated by several research groups, no consensus
has been reached on human saliva viscosity due to differences in
experimental conditions. For example, in a review by Schipper
et al. [31] viscosity of unstimulated whole saliva was found to be
1.5–1.6 mPa s over a shear rate of 1–300 s1 in one study [32].
However another study found it to range from 3.8 to 8.8 mPa s at
a single shear rate of 90 s1 [33] and a viscosity of 100 mPa s was
recorded at a shear rate of 0.02 s1 in another study [34] within
this review. Research groups used different shear rates, tempera-
tures and types of rheometer and often small sample sizes. This
research aims to address these issues by using physiological tem-
perature and assessing viscosity across a wide range of shear rates.
It is well known that the surface tension of the medium also
affects the rate of dissolution [9]. A high interfacial tension reduces
wetting of the drug particles and reduces the rate of dissolution.
Wetting can be improved by the addition of surfactants, reducing
interfacial tension and increasing the rate of dissolution, and it is
a common practice to add surfactants to dissolution media [35].
Although many studies have investigated the ﬁlm forming proper-
ties of saliva, as well as salivary pellicle thickness and composition
[36], few studies have focussed on the surface tension of whole
human saliva [23]. Literature regarding the surface tension of sal-
iva uses variable experimental designs including different temper-
atures and sites in the oral cavity, and often small or non-speciﬁed
numbers of participants [37,38]. Further clariﬁcation of thisparameter is therefore required, using a sufﬁcient number of sam-
ples and physiologically relevant temperature.
Despite not directly affecting media choice and composition,
salivary ﬂow rate is an important factor when developing a biorel-
evant dissolution model [6]. The volume available for dissolution,
or ﬂow rate, should reﬂect physiological conditions since this
affects the concentration gradient of solvated API molecules and
saturation of the bulk ﬂuid. Salivary ﬂow rate has been investi-
gated; however, most groups investigated either US [24] or SS
[39]. Since inter-individual variation is so vast in these studies,
ﬂow rate should be considered for US and SS in the same individual
to allow accurate comparison of stimulation states.
Many research groups performing dissolution tests modelling
the oral environment have not taken into account the key charac-
teristics described above and have used simple media such as
water or phosphate buffered saline (PBS) [3,40]. The most likely
reason for that is the lack of availability of sufﬁcient data on the
characteristics of human saliva. In addition, many commercial
[41] and literature formulations [42] for simulated salivary ﬂuids
(SSF) exist. In fact, one article in the year 2000 identiﬁed 60 artiﬁ-
cial salivas of differing compositions. Whilst it is possible that
some of these 60 compositions may be appropriate for dissolution
studies, information regarding parameters key to dissolution test-
ing is not available [43]. It is also difﬁcult to select the single most
appropriate SSF without a clear understanding of human salivary
characteristics, and therefore these SSFs are rarely used in dissolu-
tion testing. Saliva is a complex mixture containing 99% water, but
additionally contains numerous electrolytes, small organic mole-
cules such as hormones and glucose, and proteins such as immu-
noglobulins, enzymes and glycoproteins, which may have a huge
impact on dissolution [44].
Therefore, the aim of this work was to characterise stimulated
and unstimulated human saliva for the key characteristics relevant
to dissolution to provide a platform of reference for the future
selection or development of oral dissolution media that would be
representative of human saliva. The saliva ﬂow rate was assessed
in this work to aid development of oral dissolution models. Age
and gender related differences were also investigated for each
parameter. To the best of our knowledge, this is a ﬁrst work in
which the key parameters relevant to drug dissolution – pH, buffer
capacity, viscosity, surface tension and ﬂow rate – are assessed
simultaneously for both stimulated and unstimulated whole
human saliva with a sufﬁcient number of participants to draw sta-
tistically meaningful conclusions.2. Methods and instrumentation
2.1. Human volunteers
All saliva samples were collected in accordance with ethical
approval number R12122013 SoP TTTFS, Faculty of Medicine and
Health Sciences Research Ethics Committee, Queens Medical Cen-
tre, Nottingham University Hospitals. Participation was voluntary
and informed written consent was obtained. All data were held
in accordance with the Data Protection Act.
Participants were recruited from the University of Nottingham
and were healthy adult volunteers. Exclusion criteria included
chronic or acute illness in the past 3 months, cold or ﬂu symptoms,
oral health concerns and any medication, with the exception of
contraception. Participants were asked not to eat, drink, smoke
or use oral hygiene for 2 h prior to donation. Donations took place
at approximately 3 pm in the afternoon to avoid diurnal salivary
changes. The study group demographics are shown in Table 1.
The study group was mostly Caucasian (26 of 30 participants).
Table 1
Study group demographic data.
Total number of participants 30
Age (mean ± S.D. (range)) 26.13 ± 3.55 (20–35)
Age 20–27 22
Age 28–35 8
Male 13
Female 17
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Fig. 1. The viscosity (mean ± S.D.) of US and SS (n = 30, triplicates) at different shear
rates. A statistically signiﬁcant difference in viscosity was observed between US and
SS at every shear rate recorded (p < 0.0001, Wilcoxon matched pairs test). (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred
to the web version of this article.)
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Participants were asked ﬁrstly to donate an unstimulated saliva
sample by draining their saliva via a sterile disposable funnel into
two 15 mL polypropylene sterile graduated centrifuge tubes (Gre-
iner Bio-One, UK) and one 1.5 mL polypropylene graduated micro-
centrifuge tube (Sarstedt, UK). Samples were collected in 3
different vessels to allow for separate defrosting for each charac-
terisation. For each type of saliva (US and SS), the following was
collected: 10 mL for buffer capacity, 6 mL for viscosity and
1.5 mL for surface tension measurement. This allowed for a slight
excess for each measurement. The time taken to donate each vol-
ume was recorded using a stopwatch and the exact volume was
used to calculate ﬂow rate for each sample.
Participants then donated a stimulated saliva sample. For this,
they were asked to continually chew a 5 cm  5 cm piece of Para-
ﬁlm [25,26,45,46] and repeat the donations following this stimu-
lation. Stimulation was controlled by regulating the size of the
piece of Paraﬁlm, and the same volume of saliva was collected
each time. Samples were immediately tested for pH, ﬂash frozen
in liquid nitrogen and then stored at 80 C until being defrosted
for characterisation. No signiﬁcant difference in pH was observed
between fresh and defrosted samples (paired t-test).
2.3. Viscosity
AModular Compact Cone-Plate RheometerMCR 302 (Anton Paar
GmbH, Germany) was used. The cone used was a CP50-2-SN30270
with diameter 49.972 mm, angle 2.016, truncation 211 lm. Analy-
sis was carried out at 37 C. 8 points per decadewere used for 3 dec-
adeswith shear rate increasing logarithmically from1 to 1000 s1. A
total of 25 points were made, 1 point per minute. Rheoplus analysis
software (Anton Paar GmbH, Germany) was used. The sample vol-
ume was 1.2 mL. Saliva was analysed in triplicate for each partici-
pant for US and SS. A range of shear rates was used to assess
whether saliva exhibits non-Newtonian behaviour. A shear rate of
4 s1 corresponds to movement of particles across the tongue, 60
corresponds to swallowing and 160 s1 to speech, whilst shear rates
of 10–500 s1 have been proposed to reﬂect the shear during eating.
We therefore used 1–1000 s1 to encompass values that are likely to
be presented in the oral cavity [47].
2.4. Surface tension
A DSA 100 Drop Shape Analyser with DSA 4 software (Kruss
GmbH, Germany) using pendant drop method for surface tension
analysis with Laplace–Young computational method was
employed. Temperature was set to 37 C using an MB-5 heat circu-
lator (Julabo GmbH, Germany) with water bath. Measurements
were taken immediately after droplet formation. Samples were
measured with 5 replicates.
2.5. pH
An S220 seven compact pH/ion meter was used with InLab
Science Pro electrode (SI 343 071, Mettler Toledo, Switzerland).
The pH meter was accurate to ±0.002 pH units and a 3 pointcalibration was used at pH 4, 7 and 10. The pH of human saliva
was measured immediately after collection prior to freezing the
samples in liquid nitrogen and storing at 80 C. The pH was mea-
sured in triplicate for each participant for both US and SS.
2.6. Buffer capacity
A 4 mL saliva sample was allowed to warm to 37 C in the test
tube. Temperature was maintained using a water bath in which the
test tube for titration was placed. The beaker was placed on an RCT
basic hotplate stirrer (IKA Works GmbH, Germany) with tempera-
ture probe. Initial pH was tested. The sample was then titrated
with 0.01 M HCl at 37 C until a decrease in pH of 1 unit was
observed. Buffer capacity in mmol H+/L saliva was calculated from
the volume of acid added. Stirring speed was set such that the
added HCl was adequately mixed throughout the bulk of the sam-
ple without forming a vortex. A 100 mm  23 mm B19/26 glass
test tube was used (supplied by Scientiﬁc Glassware Supplies,
UK). Human saliva was analysed in duplicate for each participant
for each type of saliva.
2.7. Statistical analysis
Prior to experiments, the number of study participants was
determined using a power calculation [48]. With 80% power and
a level of signiﬁcance of p < 0.05, 95% signiﬁcance, a sample size
of 8–34 participants is sufﬁcient to detect small to very large dif-
ferences, with sample size being inversely proportional to the dif-
ference to be detected.
Following the completion of the experiments, the normal distri-
bution of the results in each group was tested using a D’Agostino &
Pearson omnibus normality test. Where two normally distributed
groups were compared, a t-test was used (either paired or
unpaired). If one or both groups were not normally distributed, a
Wilcoxon matched pairs test was used for paired samples, and a
Mann–Whitney U-test was used for unpaired samples. p < 0.05
was considered signiﬁcant in all cases.3. Results
3.1. Viscosity
The viscosity of US and SS are described in Fig. 1. SS was shown
to have a lower viscosity, and a statistically signiﬁcant difference in
viscosity was observed between US and SS at every shear rate
recorded with p < 0.0001 (Wilcoxon matched pairs test).
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p < 0.05) in US viscosity was observed between males and females
at 5 shear rates in the lower shear rate range, with male saliva
showing higher viscosity (Fig. 2A). This trend appears to continue
across the remainder of the viscosity proﬁle. Practically no differ-
ence was observed for SS between male and female groups, with
a statistically signiﬁcant difference (Mann–Whitney U-test,
p < 0.01) observed at just one shear rate (Fig. 2B).
The viscosity of US was signiﬁcantly higher for the age group
28–35 compared to 20–27 at 3 shear rates (Mann–Whitney U-test,
p < 0.05, Fig. 3A). This trend also appears to continue across the rest
of the viscosity proﬁle. For SS, no signiﬁcant difference was
observed between the two age groups (Fig. 3B).B
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The surface tension for US and SS is shown in Fig. 4. The surface
tension of US was very similar to SS, with no signiﬁcant difference
observed between the two types of saliva (paired t-test). Note the
variability between individuals in surface tension of saliva was
very low.
The surface tension of human saliva (Table 2) showed no signif-
icant difference between males and females for US or SS. In addi-
tion, no signiﬁcant difference in surface tension of human saliva
was observed between different age groups for US or SS.1 10 100 1000
Shear rate
Fig. 3. Panel A: The viscosity (mean ± S.D.) of US for participants age 20–27 (n = 22,
triplicates) and age 28–35 (n = 8, triplicates) at different shear rates. ⁄Signiﬁcant
differences between age groups (MannWhitney test, p < 0.05). Panel B: The viscosity
(mean ± S.D.) of SS for participants age 20–27 (n = 22, triplicates) and age 28–353.3. pH
SS had a higher pH than US (Fig. 5) and a statistically signiﬁcant
difference was observed between the two groups according to a
paired t-test (p < 0.0001).1 10 100 1000
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Fig. 2. Panel A: The viscosity (mean ± S.D.) of US for males (n = 13, triplicates) and
females (n = 17, triplicates) at different shear rates. ⁄Signiﬁcant difference between
males and females (Mann–Whitney U-test, p < 0.05). Panel B: The viscosity
(mean ± S.D.) of SS for males (n = 13, triplicates) and females (n = 17, triplicates)
at different shear rates. ⁄Signiﬁcant differences between males and females (Mann–
Whitney U-test, p < 0.01). (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
(n = 8, triplicates) at different shear rates. (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 4. Surface tension of US and SS (n = 30, quintuplicate). Box represents median
value, 25th and 75th percentile. Whiskers represent maximum and minimum
values. No signiﬁcant difference in surface tension between US and SS (paired
t-test). (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)No signiﬁcant difference in pH was observed between males
and females for either US or SS. Similarly, no signiﬁcant difference
in pH was observed between age groups for US or SS (Table 3).
3.4. Buffer capacity
The buffer capacity was found to be signiﬁcantly different for
US and SS (paired t-test, p < 0.0001), with SS having a much greater
buffer capacity, as shown in Fig. 6.
Table 2
Surface tension of human saliva.
Mean (S.D.) US surface
tension (mN/m)
Mean (S.D.) SS surface
tension (mN/m)
All participants (N = 30) 58.98 (2.18) 59.69 (2.71)
Male (N = 13) 58.71 (2.06) 59.19 (3.43)
Female (N = 17) 59.18 (2.30) 60.07 (2.03)
Age 20–27 (N = 22) 58.86 (2.13) 59.49 (2.34)
Age 28–35 (N = 8) 59.30 (2.40) 60.22 (3.67)
All measurements are in quintuplicate. No signiﬁcant difference between US and SS
for all participants. No signiﬁcant differences observed between males and females,
or between age groups for US or SS.
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Fig. 5. pH of US and SS (n = 30, triplicate). Box represents median value, 25th and
75th percentile. Whiskers represent maximum and minimum values. ⁄⁄⁄⁄Signiﬁcant
difference (p < 0.0001, paired t-test). (For interpretation of the references to colour
in this ﬁgure legend, the reader is referred to the web version of this article.)
Table 3
pH of human saliva.
Mean (S.D.) US pH Mean (S.D.) SS pH
All participants (N = 30) 6.97 (0.20)a 7.40 (0.21)
Male (N = 13) 7.02 (0.23) 7.40 (0.16)
Female (N = 17) 6.93 (0.17) 7.39 (0.25)
Age 20–27 (N = 22) 6.97 (0.18) 7.40 (0.21)
Age 28–35 (N = 8) 6.98 (0.25) 7.40 (0.20)
All measurements are in triplicate.
a Signiﬁcantly different to SS (p < 0.0001, paired t-test).
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Fig. 6. Buffer capacity of US and SS (n = 30, duplicates). Box represents median
value, 25th and 75th percentile. Whiskers represent maximum and minimum
values. ⁄⁄⁄⁄Signiﬁcant difference (p < 0.0001, paired t-test). (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of
this article.)
Table 4
Buffer capacity of human saliva.
Mean (S.D.) US buffer
capacity (mmol H+/L)
Mean (S.D.) SS buffer
capacity (mmol H+/L)
All participants (N = 30) 5.93 (1.78)a 8.41 (2.02)
Male (N = 13) 6.60 (1.73) 9.39 (1.31)b
Female (N = 17) 5.42 (1.72) 7.66 (2.18)
Age 20–27 (N = 22) 5.83 (1.76) 8.44 (2.25)
Age 28–35 (N = 8) 6.21 (1.99) 8.31 (1.32)
All measurements are in duplicate.
a Signiﬁcantly different to SS (p < 0.0001, paired t-test).
b Signiﬁcantly different to SS female (p < 0.05, unpaired t-test).
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Fig. 7. Flow rate of US and SS (n = 30, triplicates). Box represents median value,
25th and 75th percentile. Whiskers represent maximum and minimum values.
⁄⁄⁄⁄Signiﬁcant difference (p < 0.0001, paired t-test). (For interpretation of the
20 S. Gittings et al. / European Journal of Pharmaceutics and Biopharmaceutics 91 (2015) 16–24No signiﬁcant difference in buffer capacity was observed for US
between males and females. However, a signiﬁcant difference in
buffer capacity was observed for SS between males and females
(unpaired t-test, p < 0.05). No signiﬁcant difference in buffer capac-
ity was observed between different age groups for US or SS
(Table 4).references to colour in this ﬁgure legend, the reader is referred to the web version
of this article.)3.5. Flow rate
As anticipated, the ﬂow rate of SS was signiﬁcantly greater than
US, shown in Fig. 7 (paired t-test, p < 0.0001).
No signiﬁcant difference in ﬂow rate was observed between
males and females for US or SS. Similarly, no signiﬁcant difference
in ﬂow rate was observed between age groups for US or SS
(Table 5).4. Discussion
4.1. Viscosity
Human saliva was found to be non-Newtonian across the range
of shear rates applied. The shear rates tested are likely to be in the
range observed in the oral cavity since it has been suggested that a
Table 5
Flow rate of human saliva.
Mean (S.D.) US ﬂow rate
(mL/min)
Mean (S.D.) SS ﬂow rate
(mL/min)
All participants (N = 30) 0.58 (0.24)a 1.51 (0.72)
Male (N = 13) 0.65 (0.20) 1.60 (0.63)
Female (N = 17) 0.52 (0.26) 1.44 (0.79)
Age 20–27 (N = 22) 0.57 (0.22) 1.46 (0.66)
Age 28–35 (N = 8) 0.61 (0.28) 1.64 (0.88)
All measurements are in triplicate.
a Signiﬁcantly different to SS (p < 0.0001, paired t-test).
Fig. 8. Structure of a single salivary gland acinus and duct showing ion movement.
Modiﬁed from Gibson and Beeley [57].
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the tongue whilst 60 s1 and 160 s1 correspond to swallowing
and speech respectively [34,47]. Furthermore, shear rates between
10 and 500 s1 have been proposed to mimic the range of shear
rates in the mouth during eating [49]. US was shown to have a
higher variability, with a greater relative standard deviation
observed for US than SS at all shear rates measured, with the
exception of the very lowest shear rate.
SS’s lower viscosity is proportional to its higher ﬂow rate, lead-
ing to an increased aqueous content, and a lower concentration of
mucins: glycoproteins with a polypeptide backbone and oligosac-
charide side chains which are thought to be responsible for the vis-
cosity of saliva [50]. It has been suggested that this is due to SS
originating predominantly from different salivary glands compared
to US [33]. SS has been suggested to have a larger proportion of
parotid secretions. However, mucins are mainly secreted from
the sublingual, submandibular and palatal glands [33]. Indeed, it
is well documented that secretions from the main salivary glands
have differing mucin proportions and thus differing viscosities. In
some cases, parotid saliva has actually been shown to demonstrate
Newtonian behaviour, further reinforcing the link between mucin
presence and shear thinning behaviour [31,51].
In human saliva, there are two main types of mucin present: a
high molecular weight (MW) mucin, MUC5B (MW 2–40 MDa),
and a low molecular weight mucin, MUC7 (MW approx.
150 kDa). The molecular structure of mucin is discussed in detail
elsewhere by Haward et al. [20] One study investigated which of
these types of mucin is responsible for modifying the viscosity of
saliva. They established that MUC5B concentration increased line-
arly with viscosity, but MUC7 did not, thus it is likely that MUC5B
is responsible for the viscosity of saliva [22].
The results obtained in this study correspond well with other
reports regarding the viscosity of US and SS since other research
groups found SS to be of lower viscosity [46,51]. The actual viscos-
ity values for US and SS in the literature vary depending on the
type of viscometer, shear rates and temperature used. However,
similar to other reports [50–52], we also observed non-Newtonian
behaviour for human saliva. This is thought to be attributed to the
destruction of the mucin networks within the samples which
undergo an irreversible breakdown upon shearing [31].4.2. Surface tension
The mean value for US was 58.98 mN/m whilst SS was slightly
higher at 59.69 mN/m. Literature reports variable values; however,
our results are similar to some other research groups. For example,
Kazakov et al. [23] measured the surface tension of US at room
temperature and found that it ranged from 68.7 to 44.9 mN/m
depending on the time after surface formation, with highest values
being obtained at 1 s after surface formation, and lowest values
representing time inﬁnity after surface formation. Kirkness et al.
found US surface tension to have a more similar mean value to
us at 57.4 mN/m in their year 2000 study [37], and 57.7 mN/m in
2005 [53]. However, these articles did not specify the number ofsamples or participants tested. Furthermore, for SS, Madsen et al.
[54] found human saliva to have an equilibrium surface tension
of 41.83 mN/m, whilst Christersson et al. [25] found it to range
from 56.2 mN/m at 30 s after surface formation to 48.5 mN/m at
600 s after surface formation.
The exact composition of surface-active molecules responsible
for the interfacial tension of saliva remains unclear. However, pro-
teinaceous and glycoproteinaceous material has been attributed to
surface activity according to numerous studies investigating the
composition of salivary pellicle [55,56] or salivary ﬁlm formation
[25,57]. In particular, proline rich proteins are thought to be pres-
ent at these interfaces [58,59]. There is also some suggestion of
‘‘surfactant associated proteins A, B, C and D’’ in saliva, which are
not structurally or functionally described [60]. Moreover, lipidic
materials such as phospholipids, fatty acids and triglycerides are
known to be present which may also play a role [23,61]. Since
we found no signiﬁcant difference between US and SS, it is likely
that the surface active components of human saliva remain
approximately constant, regardless of the stimulation state.
4.3. pH
The higher pH in the SS group can be attributed to differences in
electrolyte composition, including a greater bicarbonate concen-
tration in SS [62]. The pH of saliva is modiﬁed as it travels through
the duct system within salivary glands by the secretion and reab-
sorption of electrolytes, depicted in Fig. 8. Initially, an isotonic ﬂuid
is released in the secretory acinus. As ﬂuid travels along the duct,
reabsorption of some ions such as sodium and chloride, and secre-
tion of others such as bicarbonate and potassium occur, until a
hypotonic solution is released from the duct [44].
Each acinus may contain only serous cells, mucous cells or both.
Serous secretions are rich in electrolytes and enzymes, whereas
mucous secretions are rich in glycoproteins. The parotid gland
has predominantly serous secretion. Upon stimulation of saliva,
there is a greater parotid gland output, thus a greater release of
bicarbonate rich serous secretion. This coincides with a lower
mucin concentration for SS as discussed previously [44].
Literature stating the pH of human saliva reports variable val-
ues that range from 5.3 to 7.8 depending on the stimulation state
[23–25]. We found US and SS to be within this range, with mean
values of 6.97 and 7.40 for US and SS respectively (range US:
6.49–7.28, range SS: 6.96–7.69). It would be advisable to tailor dis-
solution media pH values to reﬂect these ﬁndings.
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The greater buffer capacity of SS can be attributed to the higher
bicarbonate concentration. Bicarbonate contributes approximately
80% of the buffering capacity of human saliva [63], and is found in
higher concentrations in SS due to the higher proportion of parotid
gland secretions [27]. It should be noted that unlike pH which was
measured immediately upon collection, buffer capacity was mea-
sured after ﬂash freezing and short term storage at 80 C. The
bicarbonate buffer is a dynamic system and in liquid saliva sam-
ples, carbon dioxide may be lost from the system. Although we
do not anticipate the buffer capacity to alter as a result of freezing,
this could be considered a limitation of the study.
A direct comparison with other literature is challenging due to
methodological differences. Nevertheless, the approach used here
was also used by Bardow et al. [26] who found the buffer capacity
to range from 3.1 to 6.0 mmol H+/L of saliva in US and 3.3 to
8.5 mmol H+/L of saliva in SS depending on the pH. This is compa-
rable to our values, since we found mean values to be 5.93 and
8.41 mmol H+/L of saliva for US and SS respectively. In both cases,
SS buffer capacity is higher than US. Despite methodological differ-
ences, this was also true for other literature [27]. However, we
found buffer capacity to be highly variable for both US and SS, with
relative standard deviation being 30.29% and 24.08% for US and SS
respectively. This demonstrates a high inter-individual variation,
which should be taken into account when designing a dissolution
medium.
4.5. Flow rate
The increased ﬂow rate for SS results from the parasympathetic
response to Paraﬁlm chewing which increases saliva output from
the salivary glands, in particular the parotid gland. Inter-individual
variability was high, with relative standard deviation being 41.0%
and 47.5% for US and SS respectively. In this study, US ﬂow rate
ranged from 0.23 to 1.10 mL/min with a mean value of 0.58 mL/
min whilst SS ﬂow rate ranged from 0.43 to 3.45 mL/min with a
mean value of 1.51 mL/min.
Literature is also highly variable, with one study ﬁnding a max-
imum US ﬂow rate of 2.87 mL/min [64], whilst mean SS ﬂow rate
was quoted to be just 0.9 mL/min in another study [65]. Across lit-
erature, salivary ﬂow rate has been quoted to range from 0.05 to
7.0 mL/min [24,66].
It is known that saliva undergoes diurnal changes in ﬂow rate
[66], and since a higher ﬂow rate was associated with a higher
pH, higher buffer capacity and lower viscosity in our study, the
time at which saliva is collected may affect many of the salivary
parameters investigated. Thus, the time of collection was con-
trolled and 3 pm was chosen for practical reasons.
There are three main mechanisms of salivary stimulation:
mechanical, gustatory and olfactory [44]. Dissolution testers
should consider whether the dosage form may stimulate saliva.
Crucially, the presence of a dosage form in the oral cavity such as
an orally disintegrating tablet or oromucosal formulation may
stimulate the release of saliva and therefore it may be prudent to
consider both US and SS when modelling the oral cavity. Given that
the ﬂow rate and many other parameters are so variable for human
saliva, this reinforces the requirement to model both the US and SS
states since a single set of test conditions is unlikely to represent
the range of salivary scenarios observed.
4.6. Effect of age and gender on salivary parameters
We observed signiﬁcant gender and age related differences in
viscosity of US in the low shear rate region wherein viscositywas found to be higher for males and the older age group (even
with the relatively narrow age range of volunteers). This low shear
rate region may require further investigation as statistical differ-
ences between demographic groups are only seen in this region.
Furthermore, when designing biorelevant dissolution media, this
low shear rate region should be modelled accurately. Little is
understood about the effect of age and gender on saliva viscosity.
Humphrey and Williamson [44] claim that mucin concentrations
decrease with age, but also state that secretory hypofunction is
not a normal age related phenomenon.
No differences were observed in surface tension for any demo-
graphic group. Similar to viscosity, little research has been carried
out in this area. Kazakov et al. [23] found that equilibrium surface
tension decreased with age, whereby age 5–9 > 10–15 > 40–
55 years. However, surface tension in the over 55 years group
began to increase so a linear relationship with age was not estab-
lished. The effect of gender was also not considered in that study.
Conversely, extensive literature exists detailing the inﬂuence of
age or gender on ﬂow rate. Despite this, age and gender related
effects remain unclear due to conﬂicting reports [67]. In this study,
no signiﬁcant differences in ﬂow rate were observed between
males and females, or between the two age groups. Accordingly,
other researchers also found ﬂow rate was not affected by age
[68] or gender [26]. However, some literature suggests that female
gender correlates with lower ﬂow rate [28,69] which may be
attributed to smaller salivary glands and a lower body mass index
(BMI) [70,71]. Additionally, increased age has been reported to cor-
respond with lower ﬂow rates in some cases [28,72]. In a review by
Whelton [62] decreased salivary ﬂow in older patients is described
as being secondary to disease or medication rather than directly
due to ageing, and total ﬂow is considered to be independent of
age.
No signiﬁcant differences in pH or buffer capacity were found
for any demographic group in this study except for SS buffer capac-
ity, which was found to be higher for males than females. This is in
agreement with Wikner and Soder [73] who found females had a
lower SS buffer capacity. Fenoll-Palomares et al. [28] also found
no signiﬁcant differences in pH, and higher bicarbonate concentra-
tion in men than women. However, their ﬁndings were based on
US only. Conversely, another report states gender had no effect
on buffer capacity [26]. pH has been described as higher for males
in some studies [69]. Additionally, literature describing the effect
of age on pH [69] and buffer capacity [74] reaches no consensus.
In this research, for the ﬁrst time the effect of both age and gen-
der on salivary key parameters for dissolution testing was investi-
gated. The age and gender related differences observed were not as
distinct as the differences between US and SS. Therefore, the devel-
opment of two different biorelevant dissolution media represent-
ing US and SS is strongly recommended, whilst age and gender
related differences should be kept in mind and may require further
investigation. This is particularly prudent since taste masked and
alternative oral formulations are most commonly used in the pae-
diatric and geriatric population. To note, a limitation of this study
is the relatively narrow age range employed. This is a result of
recruiting unpaid volunteers from within the University. Further
investigations of these key parameters in human saliva in a wider
age range would be necessary in order to conﬁrm trends seen in
the data. However, it is worthy to note that should the paediatric
and geriatric population be investigated, it would be inappropriate
to make conclusions about each of those populations as a single
group compared to the adult population. For example, a single
‘‘paediatric dissolution media’’ or ‘‘paediatric model’’ is unadvis-
able since a neonate differs greatly in physiology, body mass and
pharmacokinetics to an infant or teenager, and salivary parameters
may vary greatly too.
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US and SS were found to be signiﬁcantly different to each other
for pH, buffer capacity and ﬂow rate, with SS being higher for these
characteristics. No signiﬁcant difference was seen between US and
SS for surface tension. SS had lower viscosity with signiﬁcant dif-
ferences between US and SS observed across all shear rates mea-
sured. US and SS were both found to be non-Newtonian.
Signiﬁcant age and gender related differences were observed in
some parameters but were not as distinct as differences between
US and SS and may require further investigation.
These ﬁndings can be used as a platform of reference for the
development or selection of future dissolution media representing
human saliva. Since SS was found to be signiﬁcantly different to
US for all of the assessed characteristics except surface tension, this
suggests the potential requirement for the development of two dif-
ferent biorelevant dissolution media: one representing US with a
lower pH and buffer capacity but higher viscosity, and one repre-
senting SS with a higher pH and buffer capacity, but lower viscosity.
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